Portal de Periódicos da CAPES

Hodgkin's Disease in Denmark: A National Clinical Study by the Danish Hodgkin Study Group, LYGRA

1980; Wiley; Volume: 24; Issue: 4 Linguagem: Inglês

10.1111/j.1600-0609.1980.tb01591.x

0036-553X

A. M. Nordentoft, J Pedersen-Bjergaard, H Brincker, Elo Andersen, M. G. Pedersen, Janni Nielsen, Kenneth Jensen, N. I. Nissen, T. Skov Jensen, Aa. Videbæk, Mogens Krogh Jensen, S Walbom-Jørgensen,

Lung Cancer Treatments and Mutations

During the last 8 years (1971–1979) all newly diagnosed previously untreated patients with Hodgkin's disease in Denmark have been centralized to uniform staging procedures and treatment. A total of 802 patients were registered, or 2 patients /100 000. Lymphangiography was performed in 708 patients (88%), and 437 patients (55%) underwent laparotomy with splenectomy. Treatment included radiotherapy, combination chemotherapy (MOPP or similar programmes), and combined modality treatment. The overall 8‐year actuarial survival for all stages combined was 66%, and relapse‐free survival was 55%. 144 patients died of Hodgkin's disease, 23 from complications to therapy and examination procedures, and 54 died of unrelated causes. Survival was significantly better for patients without B‐symptoms, and decreased gradually with advancing age. There was a strong correlation between unfavourable prognosis and advancing stage and/or histology, but mediastinal involvement had no influence upon the prognosis. Staging laparotomy was associated with 4 deaths due to infection, and splenectomy with 10 cases of severe pneumococcal infections, 4 of which were fatal. Fatal complications due to subsequent treatment included 2 cases of cardiac arrest following mantle‐field irradiation and 3 cases of haemorrhage or sepsis following Chemotherapy. 5 cases of acute myeloid leukaemia were observed.